The IHC4+C score: an affordable and reproducible non‐molecular decision‐aid in hormone receptor‐positive breast cancer. Does it still hold value for patients in 2020?-Reference-Cited by-同舟云学术

The IHC4+C score: an affordable and reproducible non‐molecular decision‐aid in hormone receptor‐positive breast cancer. Does it still hold value for patients in 2020?

Published:2021-02-10 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Harel Nadav¹^ORCID,Cheema Steven²,Williams David³⁴⁵,Ireland‐Jenkin Kerryn⁴⁵,Fancourt Tineke¹,Dodson Andrew⁶,Yeo Belinda¹³

Affiliation:

1. Department of Medical Oncology Austin Health Melbourne Australia

2. Melbourne Medical School University of Melbourne/Austin Health Melbourne Australia

3. School of Cancer Medicine, La Trobe University Olivia Newton‐John Cancer Research Institute, Austin Health Melbourne Australia

4. Department of Anatomical Pathology Austin Health Melbourne Australia

5. Department of Clinical Pathology University of Melbourne Melbourne Australia

6. Ralph Lauren Centre for Breast Cancer Research The Royal Marsden Hospital London UK

Funder

National Breast Cancer Foundation

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13507

Reference48 articles.

1. Global patterns of cancer incidence and mortality rates and trends;Jemal A;Cancer Epidemiol Biomarkers Prev,2010

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15‐year survival: an overview of the randomised trials;EBCTCG;Lancet,2005

3. Comparisons between different polychemotherapy regimens for early breast cancer: meta‐analyses of long‐term outcome among 100,000 women in 123 randomised trials;EBCTCG;Lancet,2012

4. Survival advantage of adjuvant chemotherapy in high risk node‐negative breast cancer: ten year analysis ‐ an intergroup study;Mansour EG;J Clin Oncol,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer;Journal of Personalized Medicine;2023-10-08

2. The World Health Organization Classification of Tumors and External Quality Assurance for Immunohistochemistry and Molecular Pathology;Archives of Pathology & Laboratory Medicine;2022-06-07

3. The IHC4+C score: an affordable and reproducible non‐molecular decision‐aid in hormone receptor‐positive breast cancer. Does it still hold value for patients in 2020?;Asia-Pacific Journal of Clinical Oncology;2021-02-10